arabinofuranosyluracil and Recrudescence

arabinofuranosyluracil has been researched along with Recrudescence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, JH; Jang, ES; Jeong, SH; Kim, JW; Kim, N; Lee, DH; Lee, SS; Min, BY; Park, YS; Seong, MH; Shin, CM; Sohn, HR; Song, JC1
Baum, KF; Borucki, MJ; Cloud, GA; Crumpacker, CS; DeHertogh, DA; Gnann, JW; Joseph, WP; Lalezari, JP; Mertz, GJ; Sherrill, LC; Smith, JA; Soong, SJ; Steigbigel, RT; Tyring, SK; Whitley, RJ1
Bartz-Schmidt, KU; Heimann, K; Kirchhof, B; Rosenthal, G; Walter, P1

Trials

1 trial(s) available for arabinofuranosyluracil and Recrudescence

ArticleYear
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster St
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5

    Topics: Acyclovir; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Arabinofuranosyluracil; Double-Blind Method; Female; Herpes Zoster; Humans; Male; Middle Aged; Quality of Life; Recurrence; Treatment Outcome

1998

Other Studies

2 other study(ies) available for arabinofuranosyluracil and Recrudescence

ArticleYear
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs.
    BMC infectious diseases, 2014, Aug-13, Volume: 14

    Topics: Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Outcome

2014
Failure of sorivudine therapy in progressive outer retinal necrosis caused by varicella zoster virus.
    Australian and New Zealand journal of ophthalmology, 1998, Volume: 26, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Blindness; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Recurrence; Retinal Necrosis Syndrome, Acute; Treatment Failure

1998